Timothee Bois
Chatillon-la-borde, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 13, 2025
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Journal: The journal of allergy and clinical immunology. In practice
Published: August 13, 2024
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE.
Journal: The journal of allergy and clinical immunology. In practice
Published: August 07, 2024
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
Journal: JAMA pediatrics
Published: February 26, 2024
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
Journal: The New England journal of medicine
Published: May 10, 2023
Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children.
Journal: Allergy
Published: July 20, 2022
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Journal: The journal of allergy and clinical immunology. In practice
Published: July 09, 2021
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Journal: The Journal of allergy and clinical immunology
Published: March 30, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026